{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:06:23Z","timestamp":1788318383849,"version":"build-2803163510"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-024-01187-3","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T16:02:06Z","timestamp":1708444926000},"page":"368-376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cost-Effectiveness and Clinical Outcomes of Secondary Hyperparathyroidism Treatments in Patients with Chronic Kidney Disease"],"prefix":"10.1007","volume":"114","author":[{"given":"Wenjie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailiang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianxiu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"issue":"6","key":"1187_CR1","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1053\/j.ajkd.2010.07.012","volume":"56","author":"TI Shireman","year":"2010","unstructured":"Shireman TI, Almehmi A, Wetmore JB, Lu J et al (2010) Economic analysis of cinacalcet in combination with low-dose vitamin D versus flexible-dose vitamin D in treating secondary hyperparathyroidism in hemodialysis patients. Am J Kidney Dis 56(6):1108\u20131116. https:\/\/doi.org\/10.1053\/j.ajkd.2010.07.012","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"1187_CR2","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.3111\/13696998.2013.826665","volume":"16","author":"V Belozeroff","year":"2013","unstructured":"Belozeroff V, Lee A, Tseng S et al (2013) Cost per responder analysis in patients with secondary hyperparathyroidism on dialysis treated with cinacalcet. J Med Econ 16(9):1154\u20131162. https:\/\/doi.org\/10.3111\/13696998.2013.826665","journal-title":"J Med Econ"},{"issue":"5","key":"1187_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11914-019-00533-x","volume":"17","author":"E Bellorin-Font","year":"2019","unstructured":"Bellorin-Font E, Vasquez-Rios G, Martin KJ (2019) Controversies in the Management of Secondary Hyperparathyroidism in Chronic Kidney Disease. Curr Osteoporos Rep 17(5):333\u2013342. https:\/\/doi.org\/10.1007\/s11914-019-00533-x","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"1187_CR4","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/nu15020336","volume":"15","author":"S Barbuto","year":"2023","unstructured":"Barbuto S, Perrone V, Veronesi C et al (2023) Real-world analysis of outcomes and economic burden in patients with chronic kidney disease with and without secondary hyperparathyroidism among a sample of the Italian population. Nutrients 15(2):336. https:\/\/doi.org\/10.3390\/nu15020336","journal-title":"Nutrients"},{"issue":"8","key":"1187_CR5","doi-asserted-by":"publisher","first-page":"e3532","DOI":"10.1210\/clinem\/dgac211","volume":"107","author":"P Evenepoel","year":"2022","unstructured":"Evenepoel P, J\u00f8rgensen HS (2022) Parathyroidectomy versus calcimimetic: the lower the PTH the better? J Clin Endocrinol Metab 107(8):e3532\u2013e3533. https:\/\/doi.org\/10.1210\/clinem\/dgac211","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1187_CR6","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s11255-018-1838-5","volume":"50","author":"M Rroji","year":"2018","unstructured":"Rroji M, Spasovski G (2018) Calcimimetics versus parathyroidectomy: what is preferable? Int Urol Nephrol 50(7):1271\u20131275.https:\/\/doi.org\/10.1007\/s11255-018-1838-5","journal-title":"Int Urol Nephrol"},{"issue":"6","key":"1187_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.surg.2010.09.009","volume":"148","author":"R Schneider","year":"2010","unstructured":"Schneider R, Kolios G, Koch BM et al (2010) An economic comparison of surgical and medical therapy in patients with secondary hyperparathyroidism\u2013the German perspective. Surgery 148(6):1091\u20131099. https:\/\/doi.org\/10.1016\/j.surg.2010.09.009","journal-title":"Surgery"},{"issue":"8","key":"1187_CR8","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00423-015-1344-5","volume":"400","author":"K Lorenz","year":"2015","unstructured":"Lorenz K, Bartsch DK, Sancho JJ et al (2015) Surgical management of secondary hyperparathyroidism in chronic kidney disease\u2013a consensus report of the European Society of endocrine surgeons. Langenbecks Arch Surg 400(8):907\u2013927. https:\/\/doi.org\/10.1007\/s00423-015-1344-5","journal-title":"Langenbecks Arch Surg"},{"issue":"4","key":"1187_CR9","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1751-7176.2011.00434.x","volume":"13","author":"AN Long","year":"2011","unstructured":"Long AN, Dagogo-Jack S (2011) Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. J Clin Hypertens (Greenwich) 13(4):244\u2013251. https:\/\/doi.org\/10.1111\/j.1751-7176.2011.00434.x","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"3","key":"1187_CR10","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/1744-9987.12683","volume":"22","author":"H Komaba","year":"2018","unstructured":"Komaba H, Fukagawa M (2018) Secondary hyperparathyroidism and protein-energy wasting in end-stage renal disease. Ther Apher Dial 22(3):246\u2013250. https:\/\/doi.org\/10.1111\/1744-9987.12683","journal-title":"Ther Apher Dial"},{"issue":"5","key":"1187_CR11","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2215\/CJN.01060308","volume":"3","author":"MD Danese","year":"2008","unstructured":"Danese MD, Belozeroff V, Smirnakis K et al (2008) Consistent control of mineral and bone disorder in incident hemodialysis patients. Clin J Am Soc Nephrol 3(5):1423\u20139. https:\/\/doi.org\/10.2215\/CJN.01060308","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"1187_CR12","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1053\/j.ajkd.2011.03.032","volume":"58","author":"Y Slinin","year":"2011","unstructured":"Slinin Y, Guo H, Gilbertson DT et al (2011) Prehemodialysis care by dietitians and first-year mortality after initiation of hemodialysis. Am J Kidney Dis 58(4):583\u201390. https:\/\/doi.org\/10.1053\/j.ajkd.2011.03.032","journal-title":"Am J Kidney Dis"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-024-01187-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-024-01187-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-024-01187-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T09:03:54Z","timestamp":1711011834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-024-01187-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":12,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["1187"],"URL":"https:\/\/doi.org\/10.1007\/s00223-024-01187-3","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,20]]},"assertion":[{"value":"10 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No financial conflicts of interest were reported by the authors WenJie Zhang, Hailiang Ren,Qianxiu Liao,Jian Wu.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All procedures performed in this study involving human participants were in line with the ethical standards of the institutional research committee at the Third Hospital of Chengdu and the national research council. Informed consent was obtained from all individual participants involved in the study. Participant data were de-identified and confidentiality was ensured throughout the study and subsequent data analysis process.This study did not involve any animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}